Fang-Ding Bu

Clinical characteristics of hyperprogressive disease in NSCLC after treatment with immune checkpoint inhibitor: a systematic review and meta-analysis

P. Zhang, K. Fei, Yan Chen, 2020, BMC Cancer.

Clinical characteristics of hyperprogressive disease in NSCLC after treatment with immune checkpoint inhibitor: a systematic review and meta-analysis

K. Fei, Peng Zhang, Yan Chen, 2020, BMC Cancer.